Ni Q - Search Results

1

Role of miR-93-5p and Its Opposing Effect of Ionizing Radiation in Non-Small Cell Lung Cancer.

Ni Q, Sang K, Zhou J, Pan C. Ni Q, et al. Anal Cell Pathol (Amst). 2024 Aug 10;2024:4218464. doi: 10.1155/2024/4218464. eCollection 2024. Anal Cell Pathol (Amst). 2024. PMID: 39157415 Free PMC article.

2

Investigation of miR-93-5p and its effect on the radiosensitivity of breast cancer.

Pan C, Sun G, Sha M, Wang P, Gu Y, Ni Q. Pan C, et al. Among authors: ni q. Cell Cycle. 2021 Jun;20(12):1173-1180. doi: 10.1080/15384101.2021.1930356. Epub 2021 May 24. Cell Cycle. 2021. PMID: 34024254 Free PMC article.

3

Immunotherapy Combined with Chemotherapy as a Promising Therapy for a EGFR Exon 19 Deletion with MET Amplification Patient with Non-Small-Cell Lung Cancer: A Case Report.

Ni Q, Pan C, Dai S, Wang P. Ni Q, et al. Onco Targets Ther. 2020 Apr 9;13:3039-3044. doi: 10.2147/OTT.S243988. eCollection 2020. Onco Targets Ther. 2020. PMID: 32308434 Free PMC article.

4

Microarray data reveal potential genes that regulate triple-negative breast cancer.

Pan C, Cong A, Ni Q. Pan C, et al. Among authors: ni q. J Int Med Res. 2022 Oct;50(10):3000605221130188. doi: 10.1177/03000605221130188. J Int Med Res. 2022. PMID: 36238993 Free PMC article.

5

Radiation prevents tumor progression by inhibiting the miR‑93‑5p/EphA4/NF‑κB pathway in triple‑negative breast cancer.

Pan C, Shao S, Gu Y, Ni Q. Pan C, et al. Among authors: ni q. Oncol Rep. 2023 Apr;49(4):78. doi: 10.3892/or.2023.8515. Epub 2023 Mar 3. Oncol Rep. 2023. PMID: 36866759 Free PMC article.

6

Pathologic collision of urinary bladder urothelial carcinoma with small cell carcinoma: a case report.

Jiang W, Pan C, Guo W, Xu Z, Ni Q, Ruan Y. Jiang W, et al. Among authors: ni q. Diagn Pathol. 2023 Jul 11;18(1):80. doi: 10.1186/s13000-023-01369-x. Diagn Pathol. 2023. PMID: 37434193 Free PMC article.

7

Surufatinib combined camrelizumab as a valuable third-line rescue therapy for a patient with extensive-stage for small-cell lung cancer: a case report and literature review.

Pan C, Yu T, Han L, Hao D, Yang M, Li L, Chu L, Ni Q. Pan C, et al. Among authors: ni q. Anticancer Drugs. 2024 Mar 1;35(3):271-276. doi: 10.1097/CAD.0000000000001552. Epub 2023 Nov 21. Anticancer Drugs. 2024. PMID: 37948349 Review.

8

Case report: A promising neoadjuvant treatment option for individuals with locally advanced HER2-positive breast cancer involves the use of Pyrotinib Maleate in combination with Trastuzumab and Pertuzumab.

Pan C, Ge L, Zhang H, Sang K, Zhou J, Yi T, Ni Q. Pan C, et al. Among authors: ni q. Heliyon. 2024 Jul 11;10(14):e34511. doi: 10.1016/j.heliyon.2024.e34511. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39104479 Free PMC article.

9

Case Report: Herceptin as a Potentially Valuable Adjuvant Therapy for a Patient With Human Epidermal Growth Factor Receptor 2-Positive Advanced Esophageal Squamous Cell Carcinoma.

Han L, Pan C, Ni Q, Yu T. Han L, et al. Among authors: ni q. Front Oncol. 2021 Feb 1;10:600459. doi: 10.3389/fonc.2020.600459. eCollection 2020. Front Oncol. 2021. PMID: 33598429 Free PMC article.

10

The Treatment for a Patient with Cancer of Unknown Primary: A Case Report.

Ni Q, Lu K, Pan C, Dai S, Wang P. Ni Q, et al. Dose Response. 2021 Nov 21;19(4):15593258211056185. doi: 10.1177/15593258211056185. eCollection 2021 Oct-Dec. Dose Response. 2021. PMID: 34887715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,382 results

Search Page

Filters